Gene-edited pig organs have kept human recipients alive for weeks to months, opening a possible route around the chronic shortage of human donor organs.

Sources: [1][2]

Evidence standingEarly human
Key facts
Portal
Frontier Biotech
Stage
First-in-human, experimental
Evidence
Early human
Reversible
Irreversible
Reviewed
Jun 2026
Read time
7 min
Contents

Page status

Durable rejection control unproven · Cross-species infection surveillance needed

Key takeaways

  • Multi-gene-edited pigs reduce hyperacute rejection and remove some cross-species infection risk.
  • Early human cases and brain-dead-recipient studies have tested pig hearts and kidneys.
  • Durable rejection control and infection surveillance are the gating problems.

How it works

Pigs are engineered to remove sugars that trigger immediate human immune attack, to add human regulatory proteins, and to inactivate endogenous retroviruses. The goal is an organ the human immune system tolerates long enough to be useful.

The organ shortage is the motivation: far more people need transplants than there are human donors, and waiting-list mortality is high. A reliable animal source would change the arithmetic of transplantation.

What has been shown

Gene-edited pig hearts and kidneys have been transplanted into a small number of living recipients and into brain-dead recipients maintained for study. Recipients have survived weeks to months, with rejection and infection as recurring themes.

These are experimental cases under special authorizations, not routine care. The path forward requires controlled trials, better immunosuppression, and rigorous monitoring for cross-species infection before xenotransplantationTermXenotransplantationTransplanting organs or tissues from one species to another, such as gene-edited pig organs into humans.In glossary → could become standard.

Open questions

  • Can rejection be controlled for years rather than months?
  • How is cross-species infection risk monitored at population scale?

Watchlist

Signals that would move this entry along the evidence scale.

Controlled clinical trialsLong-term immunosuppressionEndogenous retrovirus surveillance

Key terms

References

  1. Genetically modified pig heart transplant. Griffith et al., NEJM, 2022
    First transplant of a gene-edited pig heart into a living human recipient.
  2. Xenotransplantation review. Cooper et al., Nature Reviews Nephrology, 2023
    Reviews progress, immunology, and infection considerations.

Cite this page

Future Human Atlas. “Xenotransplantation.” Last reviewed Jun 2026. https://future-human-wiki.vercel.app/articles/xenotransplantation

Suggest an edit